Intranasal Zavegepant is Effective and Well Tolerated for the Acute Treatment of Migraine: A Phase 2/3 Dose-Ranging Clinical Trial

被引：0
|
作者：
Lipton, R. B. [1 ]
Madonia, J. [2 ]
Conway, C. M. [2 ]
Thiry, A. [2 ]
Forshaw, M. [2 ]
Murphy, A. [2 ]
Jensen, C. M. [2 ]
Dubowchik, G. [2 ]
Coric, V. [2 ]
Croop, R. [2 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY 10467 USA
[2] Biohaven Pharmaceut, New Haven, CT USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0267
引用
下载
收藏
页码：99 / 99
页数：1
相关论文
共 50 条
  • [21] A Multicenter, Open-Label, Exploratory Dose-Ranging Trial of Intranasal Hydromorphone for Managing Acute Pain from Traumatic Injury
    Wermeling, Daniel P.
    Clinch, Thomas
    Rudy, Anita C.
    Dreitlein, David
    Suner, Selim
    Lacouture, Peter G.
    JOURNAL OF PAIN, 2010, 11 (01): : 24 - 31
  • [22] Rituximab Therapy for Refractory Scleritis Results of a Phase I/II Dose-Ranging, Randomized, Clinical Trial
    Suhler, Eric B.
    Lim, Lyndell L.
    Beardsley, Robert M.
    Giles, Tracy R.
    Pasadhika, Sirichai
    Lee, Shelly T.
    de Saint Sardos, Alexandre
    Butler, Nicholas J.
    Smith, Justine R.
    Rosenbaum, James T.
    OPHTHALMOLOGY, 2014, 121 (10) : 1885 - 1891
  • [23] Dose-ranging trial of transdermal microneedle zolmitriptan (C213) for the acute treatment of cluster attacks
    Joshi, S.
    Kudrow, D.
    Nagy, A. J.
    Engels, J.
    Halladay, W.
    Kellerman, D. J.
    HEADACHE, 2022, 62 : 135 - 136
  • [24] A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial OfReldesemtivIn Patients With ALS
    Shefner, Jeremy M.
    Andrews, Jinsy A.
    Genge, Angela
    Jackson, Carlayne
    Lechtzin, Noah
    Miller, Timothy M.
    Cockroft, Bettina M.
    Meng, Lisa
    Wei, Jenny
    Wolff, Andrew A.
    Malik, Fady, I
    Bodkin, Cynthia
    Brooks, Benjamin R.
    Caress, James
    Dionne, Annie
    Fee, Dominic
    Goutman, Stephen A.
    Goyal, Namita A.
    Hardiman, Orla
    Hayat, Ghazala
    Heiman-Patterson, Terry
    Heitzman, Daragh
    Henderson, Robert D.
    Johnston, Wendy
    Karam, Chafic
    Kiernan, Matthew C.
    Kolb, Stephen J.
    Korngut, Lawrence
    Ladha, Shafeeq
    Matte, Genevieve
    Mora, Jesus S.
    Needham, Merrilee
    Oskarsson, Bjorn
    Pattee, Gary L.
    Pioro, Erik P.
    Pulley, Michael
    Quan, Dianna
    Rezania, Kourosh
    Schellenberg, Kerri L.
    Schultz, David
    Shoesmith, Christen
    Simmons, Zachary
    Statland, Jeffrey
    Sultan, Shumaila
    Swenson, Andrea
    Van den Berg, Leonard H.
    Tuan Vu
    Vucic, Steve
    Weiss, Michael
    Whyte-Rayson, Ashley
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2021, 22 (3-4) : 287 - 299
  • [25] A phase I dose-ranging trial of monthly infusions of zoledronic acid for the treatment of osteolytic bone metastases
    Berenson, JR
    Vescio, RA
    Rosen, LS
    VonTeichert, JM
    Woo, M
    Swift, R
    Savage, A
    Givant, E
    Hupkes, M
    Harvey, H
    Lipton, A
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 478 - 485
  • [26] An open, dose-ranging, phase II trial of chlorproguanil/dapsone with three doses of artesunate for the treatment of acute uncomplicated Plasmodium Falciparum malaria
    Wootton, Dan
    Opara, Hyginus
    Nyirenda, Maggie
    Blencoe, Hannah
    Kanjala, Maxwell
    Baldeh, Ignatius
    Woessners, Mary
    Neate, Colin
    Duparc, Stephan
    Kirby, Paula
    Milligan, Paul
    Molyneux, Malcolm
    Dunyo, Sam
    Winstanley, Peter
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 222 - 222
  • [27] A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10mg Nasal Spray for the Acute Treatment of Migraine
    Croop, Robert
    Madonia, Jennifer
    Hould, Jennifer
    Mosher, Linda
    Lovegren, Meghan
    Coric, Vladimir
    Lipton, Richard B.
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 124 - 125
  • [28] A DOSE-RANGING AND EFFICACY PHASE 3 TRIAL OF FERRIC CITRATE (FC) AS A PHOSPHATE BINDER IN DIALYSIS PATIENTS
    Sika, Mohammed
    Smith, Mark
    Schulman, Gerald
    Kaplan, Mark
    Lewis, Julia
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A89 - A89
  • [29] Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
    Mullin, Kathleen
    Croop, Robert
    Pavlovic, Jelena
    Mosher, Linda
    Smith, Timothy
    Madonia, Jennifer
    Lovegren, Meghan
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
  • [30] Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
    Mullin, Kathleen
    Croop, Robert
    Pavlovic, Jelena M.
    Mosher, Linda
    Smith, Timothy R.
    Madonia, Jennifer
    Lovegren, Meghan
    Coric, Vladimir
    Lipton, Richard B.
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 126 - 127
12345